Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Flint
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Flint, MI

Studies commonly pay $75 to $4,500 per completed study

182 clinical trials are currently recruiting participants within 30 miles of Flint. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

182studies recruiting
5+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Flint right now

Top 25 of 182 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Genesee Cancer and Blood Disease Treatment Center — Flint, Michigan (0.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer

Metastatic Colorectal Adenocarcinoma Phase 2 Interventional 102 participants sought
Karmanos Cancer Institute at McLaren Flint — Flint, Michigan (0.8 mi) · Sponsor: Barbara Ann Karmanos Cancer Institute
See eligibility & contact on ClinicalTrials.gov (NCT07130903)

Health Impact 360: Advancing Physical, Social, and Mental Health Toward Cardiovascular Disease Prevention in Community Settings

Health Promotion, Cardiovascular Health N/A Interventional 328 participants sought
Hasselbringe Senior Center — Flint, Michigan (0.8 mi) · Sponsor: University of Michigan
See eligibility & contact on ClinicalTrials.gov (NCT07034352)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Genesee Cancer and Blood Disease Treatment Center — Flint, Michigan (0.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension

Difficult to Control Hypertension Phase 2 Interventional 120 participants sought
Aa Mrc Llc — Flint, Michigan (0.8 mi) · Sponsor: E-Star BioTech, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06343298)

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Breast Cancer, Breast Neoplasm Phase 2 Interventional 132 participants sought
McLaren Proton Therapy Center — Flint, Michigan (0.8 mi) · Sponsor: Proton Collaborative Group
See eligibility & contact on ClinicalTrials.gov (NCT01766297)

A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

Moderate to Severe Glabellar Lines Phase 3 Interventional 1,300 participants sought
Michigan Center for Research Company — Clarkston, Michigan (24.2 mi) · Sponsor: Ipsen
See eligibility & contact on ClinicalTrials.gov (NCT07435428)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07091617)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Owosso, Michigan (24.5 mi) · Sponsor: TG Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06433752)

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Retina Associates of Michigan — Grand Blanc, Michigan (7.3 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
Genesys Hurley Cancer Institute — Flint, Michigan (0.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Multiple conditions Phase 3 Interventional 158 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06589804)

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Multiple conditions Phase 2 Interventional 98 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06532279)

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06580314)

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma Phase 3 Interventional 421 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05976763)

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis, Generalized Phase 1, Phase 2 Interventional 81 participants sought
Aurinia Investigational Site — Flint, Michigan (0.8 mi) · Sponsor: Aurinia Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07596901)

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus With Hypoglycemia Phase 2 Interventional 186 participants sought
Elite Research Center — Flint, Michigan (0.8 mi) · Sponsor: Zucara Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05762107)

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Severe Alopecia Areata Phase 3 Interventional 140 participants sought
Michigan Dermatology Institute — Waterford, Michigan (26.9 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07029828)
Actively enrolling

Studies you may be able to join near Flint

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Flint

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Elite Clinical Research

★ 5.0
1397 S Linden Rd, Flint, MI 48532
(810) 820-9853

Michigan Cancer Research Consortium

302 Kensington Ave, Flint, MI 48503
(810) 762-8057

Genesys Hurley Cancer Institute

★ 3.7 (41 reviews)
302 Kensington Ave, Flint, MI 48503
(810) 762-8226
"Radiation is wonderful couldn't ask for anything better everyone is so kind and very organized,but as for his chemo doctor she is horrible don't call…"
— Diana Collins, 1★

McLaren Bariatric and Metabolic Institute

★ 3.3
3200 Beecher Rd Ste MBI, Flint, MI 48532
(810) 342-5470

Detroit Clinical Research Center

★ 5.0
30160 Orchard Lake Rd #110, Farmington Hills, MI 48334
(248) 737-5939

Clinical trials in Flint: what's recruiting

The Flint area currently has 182 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Flint, the most active research areas are:

  • Cancer & Oncology14 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Flint, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Flint

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Flint participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Flint pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Flint?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Flint safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Flint?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Flint

Other metros within reach

South Lyon, MI1,329 Ann Arbor, MI1,186 Detroit, MI1,190 Lansing, MI183 Toledo, OH208 Grand Rapids, MI456 Kalamazoo, MI107 Lorain, OH1,304

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Flint Bladder Issues Due To Spinal Cord Injury in Flint All conditions

More of MI

South Lyon1,329 Detroit1,190 Ann Arbor1,186 Grand Rapids456 Lansing183 Kalamazoo107 Muskegon61

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts